A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
- First Posted Date
- 2025-05-08
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 300
- Registration Number
- NCT06962839
A Study in Healthy People to Test How Empagliflozin is Taken up in the Body When Taken as a Whole Tablet or Dissolved in Water and Mixed With Food
- First Posted Date
- 2025-05-08
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 15
- Registration Number
- NCT06962826
A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON)
Phase 1
Not yet recruiting
- Conditions
- Cystic Fibrosis
- First Posted Date
- 2025-05-08
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 285
- Registration Number
- NCT06962852
- Locations
- 🇮🇹
Istituto G. Gaslini, Genova, Italy
🇫🇷HOP Necker, Paris, France
🇮🇹Osp. Pediatrico Bambin Gesù, Roma, Italy
A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems
- First Posted Date
- 2025-05-04
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 44
- Registration Number
- NCT06957756
- Locations
- 🇺🇸
Omega Research Orlando, LLC, Orlando, Florida, United States
🇺🇸American Research Corporation, San Antonio, Texas, United States
A Study in Healthy People to Test How 3 Different Formulations of BI 764198 Are Taken up in the Body and How This is Influenced by Food
Phase 1
Not yet recruiting
- Conditions
- Healthy
- Interventions
- Drug: BI 764198, formulation 1Drug: BI 764198, formulation 2Drug: BI 764198, formulation 3
- First Posted Date
- 2025-05-02
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 16
- Registration Number
- NCT06955754
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Phase 3
Not yet recruiting
- Conditions
- Heart Failure
- Interventions
- First Posted Date
- 2025-04-20
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 4200
- Registration Number
- NCT06935370
- Locations
- 🇩🇪
Klinikum Worms gGmbH, Worms, Germany
🇦🇷Instituto Médico DAMIC S.R.L., Cordoba, Argentina
🇦🇷Centro Medico Luquez, Cordoba, Argentina
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
Phase 2
Not yet recruiting
- Conditions
- Chronic Kidney Disease
- Interventions
- First Posted Date
- 2025-04-14
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 416
- Registration Number
- NCT06926660
- Locations
- 🇩🇪
Internistische Gemeinschaftspraxis in Bünde, Bünde, Germany
🇩🇪Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Germany
🇩🇪Synexus Clinical Research GmbH-Frankfurt-56626, Frankfurt, Germany
A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood
- First Posted Date
- 2025-04-09
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 16
- Registration Number
- NCT06917872
- Locations
- 🇩🇪
CRS Clinical Research Services Berlin GmbH, Berlin, Germany
A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 60
- Registration Number
- NCT06916702
- Locations
- 🇩🇪
Charité Research Organisation GmbH, Berlin, Germany
The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib
Not yet recruiting
- Conditions
- Pulmonary Fibrosis
- First Posted Date
- 2025-04-06
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 493
- Registration Number
- NCT06912659
© Copyright 2025. All Rights Reserved by MedPath